New CT response criteria in non-small cell lung cancer: Proposal and application in EGFR tyrosine kinase inhibitor therapy
- 22 November 2010
- journal article
- research article
- Published by Elsevier BV in Lung Cancer
- Vol. 73 (1), 63-69
- https://doi.org/10.1016/j.lungcan.2010.10.019
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Molecularly Targeted Therapy Using Bevacizumab for Non-Small Cell Lung Cancer: a Pilot Study for the New CT Response CriteriaKorean Journal of Radiology, 2010
- Response Rate Is Associated with Prolonged Survival in Patients with Advanced Non-small Cell Lung Cancer Treated with Gefitinib or ErlotinibJournal of Thoracic Oncology, 2009
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)European Journal of Cancer, 2009
- Individual patient data analysis to assess modifications to the RECIST criteriaEuropean Journal Of Cancer, 2009
- Tumor Cavitation: Impact on Objective Response Evaluation in Trials of Angiogenesis Inhibitors in Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2009
- Response-Independent Survival Benefit in Metastatic Colorectal Cancer: A Comparative Analysis of N9741 and AVF2107Journal of Clinical Oncology, 2008
- Phase II Studies of Modern Drugs Directed Against New Targets: If You Are Fazed, Too, Then Resist RECISTJournal of Clinical Oncology, 2004
- The proportion of consolidation to ground-glass opacity on high resolution CT is a good predictor for distinguishing the population of non-invasive peripheral adenocarcinomaLung Cancer, 2003
- “Early” peripheral lung cancer: prognostic significance of ground glass opacity on thin-section computed tomographic scanThe Annals of Thoracic Surgery, 2002
- New Guidelines to Evaluate the Response to Treatment in Solid TumorsJNCI Journal of the National Cancer Institute, 2000